Skip Navigation LinksHome > May 2011 - Volume 19 - Issue 3 > Atazanavir-Associated QT Interval Prolongation and Torsades...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3181fc6e51
Case Reports

Atazanavir-Associated QT Interval Prolongation and Torsades de Points in a Patient With Liver Cirrhosis: A Rare But Serious Complication

Dabiesingh, Devindra S. DO, MPH*; Psevdos, George MD†‡; Sharp, Victoria L. MD‡

Collapse Box


Although proving its effectiveness in suppressing human immunodeficiency viral (HIV) replication, atazanavir has also recently been associated with cardiac QT interval prolongation and ventricular arrhythmia. The connection rouses larger concern when other proventricular arrhythmic conditions or drugs are concomitantly involved. We present a case of a HIV-infected patient with liver cirrhosis who developed QT interval prolongation in the setting of atazanavir. Subsequently, this arrhythmia progressed to near lethal torsades de pointes while acutely coupled with an exacerbating high-dose oxycodone therapy. Once atazanavir was discontinued, QT interval times progressively normalized, and ventricular arrhythmia risk was alleviated. In conclusion, this observance encourages physicians caring for HIV-infected patients to be aware of this possible rare but emerging cardiac presentation during the treatment of patients on atazanavir therapy.

© 2011 Lippincott Williams & Wilkins, Inc.

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.